logo
Select company
Select metric
-12858.68%EBIT Margin
VS
Market
1
Sector
5
Industry
8
History
20
$ 2.52Close
$ 2.36 - $ 27 52-Week Range
Ticker Information

Ticker

AIM

Company Name

AIM IMMUNOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

AIM IMMUNOTECH INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AIM - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -15.56M-12858.68%$ 121K
3/31/2025$ -14.57M-9980.14%$ 146K
12/31/2024$ -16.73M-9844.12%$ 170K
9/30/2024$ -23.48M-12355.79%$ 190K
6/30/2024$ -27.79M-13827.86%$ 201K
3/31/2024$ -31.05M-16086.01%$ 193K
12/31/2023$ -28.96M-14337.62%$ 202K
9/30/2023$ -20.77M-10764.25%$ 193K
6/30/2023$ -19.34M-11514.29%$ 168K
3/31/2023$ -19.29M-12362.82%$ 156K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AIM IMMUNOTECH INC's latest trailing twelve months (TTM) EBIT % stands at -6526.32%.
  • Over the past 5 years, AIM IMMUNOTECH INC's average EBIT % has been -12234.16%.
  • The median EBIT % for AIM IMMUNOTECH INC during this period was -12684.95%
  • AIM IMMUNOTECH INC reached its highest EBIT % over the past 5 years at -6526.32%.
  • The lowest EBIT % recorded by AIM IMMUNOTECH INC in the same timeframe -16086.01%

AIM IMMUNOTECH INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
SILO : SILO PHARMA INC -6782.19%VIVS : VIVOSIM LABS INC -1389.44%HCWB : HCW BIOLOGICS INC -6270.17%CDIO : CARDIO DIAGNOSTICS HOLDINGS INC -31956.48%IBO : IMPACT BIOMEDICAL INC -533357.14%PMCB : PHARMACYTE BIOTECH INC -APVO : APTEVO THERAPEUTICS INC -ACXP : ACURX PHARMACEUTICALS INC -PALI : PALISADE BIO INC -GNPX : GENPREX INC -

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for AIM IMMUNOTECH INC is calculated as follows: EBIT [ $ -11.16M ] / Revenues [ $ 171K ]
(=) EBIT % [ -6526.32% ]

AIM - EBIT Margin, Last 5 years

-16086.01%

Minimum

Mar 31, 2024

-6526.32%

Maximum

Sep 30, 2020

-12234.16%

Average

-12684.95%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%